Vitamin D combined with resveratrol prevents cognitive decline in SAMP8 mice

Current Alzheimer Research

Volumn 14, Issue 8, 2017, Pages 820-833

  Cheng, Jinbo ^a   Rui, Yehua ^a   Qin, Liqiang ^a   Xu, Jiaying ^a   Han, Shufen ^a   Yuan, Linxi ^b   Yin, Xuebin ^b   Wan, Zhongxiao ^a  

^a SOOCHOW UNIVERSITY   (China)

^b Jiangsu Bio Engineering Research Centre of Selenium   (China)

Author keywords

Alzheimer's disease; Amyloid ; Cognitive function; Endoplasmic reticulum stress; Neuroinflammation; Resveratrol; Tau phosphorylation; Vitamin D

Indexed keywords

25 HYDROXYVITAMIN D; BETA SECRETASE 1; CATHEPSIN B; COLECALCIFEROL; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; PROTEIN P53; RESVERATROL; SERINE; TAU PROTEIN; AMYLOID BETA PROTEIN; AMYLOID BETA-PROTEIN (1-42); AMYLOID PRECURSOR PROTEIN; ANTIOXIDANT; ASPARTIC PROTEINASE; BACE1 PROTEIN, HUMAN; GLYCOGEN SYNTHASE KINASE 3; NERVE PROTEIN; PEPTIDE FRAGMENT; SECRETASE; STILBENE DERIVATIVE; TAU-PROTEIN KINASE; VITAMIN D;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CHEMILUMINESCENCE IMMUNOASSAY; COGNITION; COGNITIVE DEFECT; COMBINATION DRUG THERAPY; CONTROLLED STUDY; DETERIORATION; ENDOPLASMIC RETICULUM STRESS; ESCAPE BEHAVIOR; HALF LIFE TIME; HIPPOCAMPUS; LATENT PERIOD; MALE; MEMORY DISORDER; MORRIS WATER MAZE TEST; MOUSE; NERVOUS SYSTEM INFLAMMATION; NEUROPROTECTION; NONHUMAN; PARIETAL CORTEX; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SENESCENCE ACCELERATED MOUSE; VITAMIN BLOOD LEVEL; AGING; ANIMAL; BLOOD; BRAIN; DISEASE MODEL; DRUG EFFECTS; METABOLISM; SIGNAL TRANSDUCTION; TUNEL ASSAY;

AGING; AMYLOID BETA-PEPTIDES; AMYLOID BETA-PROTEIN PRECURSOR; AMYLOID PRECURSOR PROTEIN SECRETASES; ANIMALS; ANTIOXIDANTS; ASPARTIC ACID ENDOPEPTIDASES; BRAIN; CATHEPSIN B; COGNITION; COGNITION DISORDERS; DISEASE MODELS, ANIMAL; DRUG THERAPY, COMBINATION; GLYCOGEN SYNTHASE KINASE 3; IN SITU NICK-END LABELING; MICE; NERVE TISSUE PROTEINS; PEPTIDE FRAGMENTS; SIGNAL TRANSDUCTION; STILBENES; TAU PROTEINS; VITAMIN D;

EID: 85018349475     PISSN: 15672050     EISSN: 18755828     Source Type: Journal    
DOI: 10.2174/1567205014666170207093455     Document Type: Article

References (62)

1. Hung CW, Chen YC, Hsieh WL, Chiou SH, Kao CL. Ageing and neurodegenerative diseases. Ageing Res Rev 9(1): S36-46 (2010).
2. Orhan IE, Sezer Senol F. Designing multi-targeted therapeutics for the treatment of Alzheimer's disease. Curr Top Med Chem 16(17):1889-96 (2016).
3. Brown J, Bianco JI, McGrath JJ, Eyles DW. 1,25-dihydroxyvitamin D3 induces nerve growth factor, promotes neurite outgrowth and inhibits mitosis in embryonic rat hippocampal neurons. Neurosci Lett 343(2): 139-43 (2003).
4. Garcion E, Wion-Barbot N, Montero-Menei CN, Berger F, Wion D. New clues about vitamin D functions in the nervous system. Trends Endocrinol Metab 13(3): 100-5 (2002).
5. Baur JA, Sinclair DA. Therapeutic potential of resveratrol: the in vivo evidence. Nat Rev Drug Discov 5(6): 493-506 (2006).
6. Breuer C, Wolf G, Andrabi SA, Lorenz P, Horn TF. Blood-brain barrier permeability to the neuroprotectant oxyresveratrol. Neurosci Lett 393(2-3): 113-8 (2006).
7. Ahmed T, Javed S, Tariq A, Samec D, Tejada S, Nabavi SF et al. Resveratrol and Alzheimer's Disease: mechanistic Insights. Mol Neurobiol 54(4): 2622-2635 (2017).
8. Witte AV, Kerti L, Margulies DS, Floel A. Effects of resveratrol on memory performance, hippocampal functional connectivity, and glucose metabolism in healthy older adults. J Neurosci 34(23): 7862-70 (2014).
9. Hayes DP. Resveratrol and vitamin D: significant potential interpretative problems arising from their mutual processes, interactions and effects. Med Hypotheses 77(5): 765-72 (2011).
10. Herrup K. Reimagining Alzheimer's disease--an age-based hypothesis. J Neurosci 30(50): 16755-62 (2010).
11. Guo JL, Lee VM. Seeding of normal tau by pathological tau conformers drives pathogenesis of Alzheimer-like tangles. J Biol Chem 286(17): 15317-31 (2011).
12. Zotova E, Nicoll JA, Kalaria R, Holmes C, Boche D. Inflammation in Alzheimer's disease: relevance to pathogenesis and therapy. Alzheimers Res Ther 2(1): 1 (2010).
13. Bhat NR, Thirumangalakudi L. Increased tau phosphorylation and impaired brain insulin/IGF signaling in mice fed a high fat/high cholesterol diet. J Alzheimers Dis 36(4): 781-9 (2013).
14. Vassar R, Kovacs DM, Yan R, Wong PC. The beta-secretase enzyme BACE in health and Alzheimer's disease: regulation, cell biology, function, and therapeutic potential. J Neurosci 29(41): 12787-94 (2009).
15. Hook V, Schechter I, Demuth HU, Hook G. Alternative pathways for production of beta-amyloid peptides of Alzheimer's disease. Biol Chem 389(8): 993-1006 (2008).
16. Fleck D, Garratt AN, Haass C, Willem M. BACE1 dependent neuregulin processing: review. Curr Alzheimer Res 9(2): 178-83 (2012).
17. Hook G, Hook V, Kindy M. The cysteine protease inhibitor, E64d, reduces brain amyloid-beta and improves memory deficits in Alzheimer's disease animal models by inhibiting cathepsin B, but not BACE1, beta-secretase activity. J Alzheimers Dis 26(2): 387-408 (2011).
18. Metcalfe MJ, Figueiredo-Pereira ME. Relationship between tau pathology and neuroinflammation in Alzheimer's disease. Mt Sinai J Med 77(1): 50-8 (2010).
19. Roussel BD, Kruppa AJ, Miranda E, Crowther DC, Lomas DA, Marciniak SJ. Endoplasmic reticulum dysfunction in neurological disease. Lancet Neurol 12(1): 105-18 (2013).
20. Hoozemans JJ, van Haastert ES, Nijholt DA, Rozemuller AJ, Eikelenboom P, Scheper W. The unfolded protein response is activated in pretangle neurons in Alzheimer's disease hippocampus. Am J Pathol 174(4): 1241-51 (2009).
21. Sato N, Imaizumi K, Manabe T, Taniguchi M, Hitomi J, Katayama T et al. Increased production of beta-amyloid and vulnerability to endoplasmic reticulum stress by an aberrant spliced form of presenilin 2. J Biol Chem 276(3): 2108-14 (2001).
22. Morley JE, Farr SA, Kumar VB, Armbrecht HJ. The SAMP8 mouse: a model to develop therapeutic interventions for Alzheimer's disease. Curr Pharm Des 18(8): 1123-30 (2012).
23. Morley JE, Farr SA, Flood JF. Antibody to amyloid beta protein alleviates impaired acquisition, retention, and memory processing in SAMP8 mice. Neurobiol Learn Mem 78(1): 125-38 (2002).
24. Canudas AM, Gutierrez-Cuesta J, Rodriguez MI, Acuna-Castroviejo D, Sureda FX, Camins A et al. Hyperphosphorylation of microtubule-associated protein tau in senescence-accelerated mouse (SAM). Mech Ageing Dev 126(12): 1300-4 (2005).
25. Nomura Y, Okuma Y. Age-related defects in lifespan and learning ability in SAMP8 mice. Neurobiol Aging 20(2): 111-5 (1999).
26. Latimer CS, Brewer LD, Searcy JL, Chen KC, Popovic J, Kraner SD et al. Vitamin D prevents cognitive decline and enhances hippocampal synaptic function in aging rats. Proc Natl Acad Sci U S A 111(41): E4359-66 (2014).
27. Thomas J, Garg ML, Smith DW. Dietary supplementation with resveratrol and/or docosahexaenoic acid alters hippocampal gene expression in adult C57Bl/6 mice. J Nutr Biochem 24(10): 1735-40 (2013).
28. Liu D, Zhang Q, Gu J, Wang X, Xie K, Xian X, et al. Resveratrol prevents impaired cognition induced by chronic unpredictable mild stress in rats. Prog Neuropsychopharmacol Biol Psychiatry 49: 21-9 (2014).
29. Reiter FP, Hohenester S, Nagel JM, Wimmer R, Artmann R, Wottke L, et al. 1,25-(OH)(2)-vitamin D(3) prevents activation of hepatic stellate cells in vitro and ameliorates inflammatory liver damage but not fibrosis in the Abcb4(-/-) model. Biochem Biophys Res Commun 459(2):227-33 (2015).
30. Morris RG. Toward a representational hypothesis of the role of hippocampal synaptic plasticity in spatial and other forms of learning. Cold Spring Harb Symp Quant Biol 55: 161-73 (1990).
31. Wan Z, Thrush AB, Legare M, Frier BC, Sutherland LN, Williams DB, et al. Epinephrine-mediated regulation of PDK4 mRNA in rat adipose tissue. Am J Physiol Cell Physiol 299(5): C1162-70 (2010).
32. Chen N, Zhou L, Zhang Z, Xu J, Wan Z, Qin L. Resistin induces lipolysis and suppresses adiponectin secretion in cultured human visceral adipose tissue. Regul Pept 194-195: 49-54 (2014).
33. Cheng J, Chen L, Han S, Qin L, Chen N, Wan Z. Treadmill running and rutin reverse high fat diet induced cognitive impairment in diet induced obese mice. J Nutr Health Aging 20(5): 503-8 (2016).
34. Jones KS, Schoenmakers I, Bluck LJ, Ding S, Prentice A. Plasma appearance and disappearance of an oral dose of 25-hydroxyvitamin D2 in healthy adults. Br J Nutr 107(8): 1128-37 (2012).
35. Del Valle J, Duran-Vilaregut J, Manich G, Casadesus G, Smith MA, Camins A et al. Early amyloid accumulation in the hippocampus of SAMP8 mice. J Alzheimers Dis 19(4): 1303-15 (2010).
36. Brouwer-Brolsma EM, Schuurman T, de Groot LC, Feskens EJ, Lute C, Naninck EF, et al. No role for vitamin D or a moderate fat diet in aging induced cognitive decline and emotional reactivity in C57BL/6 mice. Behav Brain Res 267: 133-43 (2014).
37. Porquet D, Casadesus G, Bayod S, Vicente A, Canudas AM, Vilaplana J, et al. Dietary resveratrol prevents Alzheimer's markers and increases life span in SAMP8. Age (Dordr) 35(5): 1851-65 (2013).
38. Bennett L, Kersaitis C, Macaulay SL, Munch G, Niedermayer G, Nigro J, et al. Vitamin D2-enriched button mushroom (Agaricus bisporus) improves memory in both wild type and APPswe/PS1dE9 transgenic mice. PLoS One 8(10): e76362 (2013).
39. Briones TL, Darwish H. Vitamin D mitigates age-related cognitive decline through the modulation of pro-inflammatory state and decrease in amyloid burden. J Neuroinflammation 9: 244 (2012).
40. Dampf Stone A, Batie SF, Sabir MS, Jacobs ET, Lee JH, Whitfield GK, et al. Resveratrol potentiates vitamin D and nuclear receptor signaling. J Cell Biochem 116(6): 1130-43 (2015).
41. Hardy J. The amyloid hypothesis for Alzheimer's disease: a critical reappraisal. J Neurochem 110(4): 1129-34 (2009).
42. Finder VH, Glockshuber R. Amyloid-beta aggregation. Neurodegener Dis 4(1): 13-27 (2007).
43. Shankar GM, Li S, Mehta TH, Garcia-Munoz A, Shepardson NE, Smith I, et al. Amyloid-beta protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory. Nat Med 14(8): 837-42 (2008).
44. McLean CA, Cherny RA, Fraser FW, Fuller SJ, Smith MJ, Beyreuther K, et al. Soluble pool of Abeta amyloid as a determinant of severity of neurodegeneration in Alzheimer's disease. Ann Neurol 46(6): 860-6 (1999).
45. Takashima A. GSK-3beta and memory formation. Front Mol Neurosci 5: 47 (2012).
46. Hochgrafe K, Sydow A, Mandelkow EM. Regulatable transgenic mouse models of Alzheimer disease: onset, reversibility and spreading of tau pathology. FEBS J 280(18): 4371-81 (2013).
47. Hu YY, He SS, Wang X, Duan QH, Grundke-Iqbal I, Iqbal K, et al. Levels of nonphosphorylated and phosphorylated tau in cerebrospinal fluid of Alzheimer's disease patients: an ultrasensitive bienzyme-substrate-recycle enzyme-linked immunosorbent assay. Am J Pathol 160(4): 1269-78 (2002).
48. Xiao J, Perry G, Troncoso J, Monteiro MJ. alpha-calciumcalmodulin-dependent kinase II is associated with paired helical filaments of Alzheimer's disease. J Neuropathol Exp Neurol 55(9): 954-63 (1996).
49. Rogers J, Webster S, Lue LF, Brachova L, Civin WH, Emmerling M, et al. Inflammation and Alzheimer's disease pathogenesis. Neurobiol Aging 17(5): 681-6 (1996).
50. Simpson JE, Ince PG, Lace G, Forster G, Shaw PJ, Matthews F, et al. Astrocyte phenotype in relation to Alzheimer-type pathology in the ageing brain. Neurobiol Aging 31(4): 578-90 (2010).
51. Medeiros R, LaFerla FM. Astrocytes: conductors of the Alzheimer disease neuroinflammatory symphony. Exp Neurol 239: 133-8 (2013).
52. Kester MI, Teunissen CE, Crimmins DL, Herries EM, Ladenson JH, Scheltens P, et al. Neurogranin as a cerebrospinal fluid biomarker for synaptic loss in symptomatic Alzheimer disease. JAMA Neurol 72(11): 1275-80 (2015).
53. Lee YS, Silva AJ. The molecular and cellular biology of enhanced cognition. Nat Rev Neurosci 10(2): 126-40 (2009).
54. Nicolas CS, Amici M, Bortolotto ZA, Doherty A, Csaba Z, Fafouri A, et al. The role of JAK-STAT signaling within the CNS. JAKSTAT 2(1): e22925 (2013).
55. Thomas J, Garg ML, Smith DW. Dietary resveratrol supplementation normalizes gene expression in the hippocampus of streptozotocin-induced diabetic C57Bl/6 mice. J Nutr Biochem 25(3): 313-8 (2014).
56. Ohyagi Y, Asahara H, Chui DH, Tsuruta Y, Sakae N, Miyoshi K, et al. Intracellular Abeta42 activates p53 promoter: a pathway to neurodegeneration in Alzheimer's disease. FASEB J 19(2): 255-7 (2005).
57. Singh CK, George J, Ahmad N. Resveratrol-based combinatorial strategies for cancer management. Ann NY Acad Sci 1290: 113-21 (2013).
58. Shen T, Wang XN, Lou HX. Natural stilbenes: an overview. Nat Prod Rep 26(7): 916-35 (2009).
59. Sun P, Liang JL, Kang LZ, Huang XY, Huang JJ, Ye ZW, et al. Increased resveratrol production in wines using engineered wine strains Saccharomyces cerevisiae EC1118 and relaxed antibiotic or auxotrophic selection. Biotechnol Prog 31(3): 650-5 (2015).
60. Sales JM, Resurreccion AV. Resveratrol in peanuts. Crit Rev Food Sci Nutr 54(6): 734-70 (2014).
61. Lu Q, Zhao Q, Yu QW, Feng YQ. Use of pollen solid-phase extraction for the determination of trans-resveratrol in peanut oils. J Agric Food Chem 63(19): 4771-6 (2015).
62. Walle T. Bioavailability of resveratrol. Ann NY Acad Sci 1215: 9-15 (2011).